Dynavax Technologies Stock Book Value Per Share

DVAX Stock

USD 12.96 0.03 0.23%

Dynavax Technologies fundamentals help investors to digest information that contributes to Dynavax Technologies' financial success or failures. It also enables traders to predict the movement of Dynavax Stock. The fundamental analysis module provides a way to measure Dynavax Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dynavax Technologies stock.

	Last Reported	Projected for Next Year
Book Value Per Share	4.83	5.07
Tangible Book Value Per Share	4.82	5.06

Book Value Per Share is likely to rise to 5.07 in 2024. Tangible Book Value Per Share is likely to rise to 5.06 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Dynavax Technologies Company Book Value Per Share Analysis

Dynavax Technologies' Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Book Value per Share

Common Equity

Average Shares

More About Book Value Per Share | All Equity Analysis

Current Dynavax Technologies Book Value Per Share

5.19 X

Most of Dynavax Technologies' fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dynavax Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Dynavax Book Value Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Dynavax Technologies is extremely important. It helps to project a fair market value of Dynavax Stock properly, considering its historical fundamentals such as Book Value Per Share. Since Dynavax Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dynavax Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dynavax Technologies' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Accounts Payable	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Total Current Assets	Net Receivables	Good Will	Intangible Assets	Long Term Debt	Short Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.85	-0.49	0.86	0.13	0.8	0.19	0.91	0.62	0.11	0.97	0.84	-0.57	-0.1	0.87	-0.3	0.83	0.78	0.77	0.81	-0.61	0.86	0.9	0.93
Total Stockholder Equity	0.85		-0.21	0.48	0.04	0.96	0.21	0.61	0.2	0.18	0.93	0.59	-0.54	-0.16	0.61	-0.14	0.99	0.59	0.52	0.59	-0.74	0.87	0.94	0.73
Retained Earnings	-0.49	-0.21		-0.63	-0.67	-0.26	0.02	-0.74	-0.39	-0.36	-0.41	-0.41	0.46	-0.1	-0.7	0.7	-0.11	-0.83	-0.74	-0.8	0.12	-0.27	-0.25	-0.57
Total Liab	0.86	0.48	-0.63		0.19	0.43	0.12	0.95	0.85	0.01	0.75	0.84	-0.44	-0.01	0.88	-0.37	0.45	0.74	0.8	0.8	-0.32	0.62	0.61	0.87
Accounts Payable	0.13	0.04	-0.67	0.19		0.17	-0.08	0.36	-0.1	0.54	0.14	-0.03	-0.4	0.15	0.41	-0.42	-0.02	0.55	0.5	0.55	-0.07	0.09	0.06	0.19
Short Term Investments	0.8	0.96	-0.26	0.43	0.17		0.2	0.59	0.07	0.4	0.91	0.44	-0.54	-0.1	0.66	-0.13	0.96	0.6	0.6	0.61	-0.84	0.81	0.94	0.72
Common Stock	0.19	0.21	0.02	0.12	-0.08	0.2		0.09	0.15	-0.01	0.19	0.19	0.5	-0.17	0.09	0.52	0.19	0.05	0.05	-0.03	0.0	0.19	0.12	0.17
Property Plant Equipment	0.91	0.61	-0.74	0.95	0.36	0.59	0.09		0.72	0.15	0.83	0.77	-0.6	-0.09	0.91	-0.48	0.57	0.86	0.84	0.91	-0.47	0.67	0.72	0.9
Current Deferred Revenue	0.62	0.2	-0.39	0.85	-0.1	0.07	0.15	0.72		-0.47	0.46	0.73	-0.15	-0.11	0.51	-0.23	0.18	0.45	0.4	0.49	-0.02	0.36	0.32	0.58
Net Debt	0.11	0.18	-0.36	0.01	0.54	0.4	-0.01	0.15	-0.47		0.2	-0.14	-0.23	0.14	0.46	-0.11	0.18	0.36	0.54	0.36	-0.36	0.18	0.25	0.31
Total Current Assets	0.97	0.93	-0.41	0.75	0.14	0.91	0.19	0.83	0.46	0.2		0.71	-0.59	-0.09	0.82	-0.24	0.92	0.73	0.74	0.76	-0.75	0.87	0.97	0.89
Net Receivables	0.84	0.59	-0.41	0.84	-0.03	0.44	0.19	0.77	0.73	-0.14	0.71		-0.39	-0.12	0.72	-0.25	0.55	0.63	0.59	0.68	-0.14	0.75	0.57	0.81
Good Will	-0.57	-0.54	0.46	-0.44	-0.4	-0.54	0.5	-0.6	-0.15	-0.23	-0.59	-0.39		-0.05	-0.57	0.54	-0.51	-0.53	-0.55	-0.66	0.57	-0.45	-0.59	-0.5
Intangible Assets	-0.1	-0.16	-0.1	-0.01	0.15	-0.1	-0.17	-0.09	-0.11	0.14	-0.09	-0.12	-0.05		0.09	-0.09	-0.15	0.03	0.31	-0.05	0.01	-0.13	-0.11	-0.14
Long Term Debt	0.87	0.61	-0.7	0.88	0.41	0.66	0.09	0.91	0.51	0.46	0.82	0.72	-0.57	0.09		-0.4	0.59	0.85	0.97	0.89	-0.51	0.71	0.74	0.94
Short Term Debt	-0.3	-0.14	0.7	-0.37	-0.42	-0.13	0.52	-0.48	-0.23	-0.11	-0.24	-0.25	0.54	-0.09	-0.4		-0.07	-0.61	-0.41	-0.58	0.05	-0.17	-0.14	-0.31
Net Tangible Assets	0.83	0.99	-0.11	0.45	-0.02	0.96	0.19	0.57	0.18	0.18	0.92	0.55	-0.51	-0.15	0.59	-0.07		0.53	0.49	0.54	-0.77	0.86	0.95	0.71
Capital Surpluse	0.78	0.59	-0.83	0.74	0.55	0.6	0.05	0.86	0.45	0.36	0.73	0.63	-0.53	0.03	0.85	-0.61	0.53		0.83	0.96	-0.31	0.73	0.61	0.84
Deferred Long Term Liab	0.77	0.52	-0.74	0.8	0.5	0.6	0.05	0.84	0.4	0.54	0.74	0.59	-0.55	0.31	0.97	-0.41	0.49	0.83		0.85	-0.49	0.6	0.65	0.83
Long Term Debt Total	0.81	0.59	-0.8	0.8	0.55	0.61	-0.03	0.91	0.49	0.36	0.76	0.68	-0.66	-0.05	0.89	-0.58	0.54	0.96	0.85		-0.37	0.73	0.66	0.88
Short Long Term Debt	-0.61	-0.74	0.12	-0.32	-0.07	-0.84	0.0	-0.47	-0.02	-0.36	-0.75	-0.14	0.57	0.01	-0.51	0.05	-0.77	-0.31	-0.49	-0.37		-0.46	-0.85	-0.5
Net Invested Capital	0.86	0.87	-0.27	0.62	0.09	0.81	0.19	0.67	0.36	0.18	0.87	0.75	-0.45	-0.13	0.71	-0.17	0.86	0.73	0.6	0.73	-0.46		0.85	0.85
Net Working Capital	0.9	0.94	-0.25	0.61	0.06	0.94	0.12	0.72	0.32	0.25	0.97	0.57	-0.59	-0.11	0.74	-0.14	0.95	0.61	0.65	0.66	-0.85	0.85		0.82
Capital Stock	0.93	0.73	-0.57	0.87	0.19	0.72	0.17	0.9	0.58	0.31	0.89	0.81	-0.5	-0.14	0.94	-0.31	0.71	0.84	0.83	0.88	-0.5	0.85	0.82

Click cells to compare fundamentals

The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.

Competition

Predict Dynavax Technologies

Book Value Per Share Over Time

Dynavax Common Stock Shares Outstanding

Common Stock Shares Outstanding

135.17 Million

At this time, Dynavax Technologies' Common Stock Shares Outstanding is fairly stable compared to the past year.

In accordance with the recently published financial statements, the book value per share of Dynavax Technologies is about 5.188 times. This is 405.18% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The book value per share for all United States stocks is 99.73% higher than that of the company.

Dynavax Book Value Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dynavax Technologies' direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dynavax Technologies could also be used in its relative valuation, which is a method of valuing Dynavax Technologies by comparing valuation metrics of similar companies.

Dynavax Technologies is currently under evaluation in book value per share category among its peers.

Dynavax Technologies ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Dynavax Technologies' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Dynavax Technologies' managers, analysts, and investors.

Environmental

Governance

Social

Dynavax Fundamentals

	Return On Equity	0.0318
	Return On Asset	-0.0038
	Profit Margin	0.08 %
	Operating Margin	0.15 %
	Current Valuation	1.19 B
	Shares Outstanding	131.46 M
	Shares Owned By Insiders	0.33 %
	Shares Owned By Institutions	99.67 %
	Number Of Shares Shorted	17.9 M
	Price To Earning	6.95 X
	Price To Book	2.50 X
	Price To Sales	6.53 X
	Revenue	232.28 M
	Gross Profit	448.22 M
	EBITDA	9.67 M
	Net Income	(6.39 M)
	Cash And Equivalents	518.17 M
	Cash Per Share	4.10 X
	Total Debt	256.91 M
	Debt To Equity	0.61 %
	Current Ratio	2.77 X
	Book Value Per Share	5.19 X
	Cash Flow From Operations	100.56 M
	Short Ratio	6.58 X
	Earnings Per Share	0.15 X
	Target Price	24.6
	Number Of Employees	408
	Beta	1.34
	Market Capitalization	1.7 B
	Total Asset	997.1 M
	Retained Earnings	(930.58 M)
	Working Capital	796.92 M
	Current Asset	199.95 M
	Current Liabilities	28.79 M
	Net Asset	997.1 M

About Dynavax Technologies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Dynavax Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dynavax Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dynavax Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC